Clinical Trials Directory

Trials / Unknown

UnknownNCT01450423

Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy

Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy Aged 15-50: A Randomized Controlled Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Lars Bo Andersen · Academic / Other
Sex
All
Age
15 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Epilepsy is a chronic neurologic disorder characterized by seizures. Beside seizures people suffering from epilepsy experience several challenges related to education, work and everyday life such as learning-, problem-solving-, memory-, concentration-, attention difficulties and fatigue. It is generally approved that physical activity (PA) has a positive effect on physical as well as mental factors. However, people with epilepsy are found to be less active and PA is rarely offered or recommended as supplement to anti-epileptic medical treatment. Few studies have investigated the effect of PA in subjects with epilepsy and additional studies of high methodical quality are needed to enable evidence-based information and counselling. This study is carried through as a randomized controlled trial which investigates the effect of participation in a 10-week cardio exercise program in people with Juvenile Myoclonic Epilepsy aged 15-50. The study hypothesis is that participation in a 10-week cardio exercise program will induce a positive change in cognitive function (concentration and attention) and possibly in brain-derived neurotrophic factor (BDNF). In addition it is expected that the intensity and duration of the 10-week cardio exercise program is sufficient to cause changes in physiological parameters related to a reduced risk of lifestyle diseases.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical activityParticipation in a 10-week supervised cardio exercise program two-three times a week. Each training session consists of 10 minutes of warm-up, 20 minutes treadmill run/walk and 30 minutes cycling. Heart rate (HR) is monitored during each session. Week 1-5: at least 15 minutes above 75% of HRmax in each session. Week 6-10: at least one session above 75% HRmax.

Timeline

Start date
2011-09-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2011-10-12
Last updated
2011-10-12

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01450423. Inclusion in this directory is not an endorsement.